Ventyx biosciences to report fourth quarter and full year 2022 financial results on march 23, 2023

Encinitas, calif., march 15, 2023 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx), (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that it will report financial results for the fourth quarter and full year 2022 after market close on march 23, 2023. company management will host a conference call and webcast beginning at 4:30 p.m. et/ 1:30 p.m. pt that day to discuss the financial results and highlight recent pipeline and business progress.
VTYX Ratings Summary
VTYX Quant Ranking